Stock Analysis on Net

Celgene Corp. (NASDAQ:CELG)

This company has been moved to the archive! The financial data has not been updated since October 31, 2019.

Cash Flow Statement 

The cash flow statement provides information about a company cash receipts and cash payments during an accounting period, showing how these cash flows link the ending cash balance to the beginning balance shown on the company balance sheet.

The cash flow statement consists of three parts: cash flows provided by (used in) operating activities, cash flows provided by (used in) investing activities, and cash flows provided by (used in) financing activities.

Celgene Corp., consolidated cash flow statement

US$ in millions

Microsoft Excel
12 months ended: Dec 31, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015 Dec 31, 2014
Net income 4,046 2,940 1,999 1,602 2,000
Depreciation 160 134 121 115 104
Amortization 475 337 384 294 269
Impairment charges 31 1,679 489 49 133
Deferred income taxes 32 (1,330) (344) (33) (272)
Change in value of contingent consideration and success payments 19 (1,350) 21 (8) 49
Gain on sale of business (38)
Net (gain) loss on sales of debt securities available-for-sale and equity investments 18 (61) (7) (84) 5
Fair value adjustments on equity investments (317)
Share-based compensation expense 921 644 606 577 448
Share-based employee benefit plan expense 33 34 40 35 41
Derivative instruments 3 72 169 (31) (72)
Other, net (15) (24) (10) 19 (14)
Accounts receivable (178) (236) (222) (305) (166)
Inventory 82 (42) (55) (51) (57)
Other operating assets (55) (73) 94 (326) 53
Accounts payable and other operating liabilities 290 273 619 533 252
Income tax payable (393) 2,229 112 61 39
Payment of contingent consideration (22) (9) (14)
Deferred revenue 41 20 7 37 8
Change in current assets and liabilities, excluding the effect of acquisitions (235) 2,171 546 (50) 115
Adjustments to reconcile net income to net cash provided by operating activities 1,125 2,306 1,977 882 806
Net cash provided by operating activities 5,171 5,246 3,976 2,484 2,806
Proceeds from sales of debt securities available-for-sale 3,388 5,872 633 3,800 2,176
Purchases of debt securities available-for-sale (675) (8,163) (1,281) (1,889) (2,661)
Capital expenditures (330) (279) (236) (286) (150)
Proceeds from sales of equity investment securities 96 116 15 92
Purchases of equity investment securities (249) (410) (132) (273) (67)
Payments for acquisition of businesses, net of cash acquired (8,648) (7,695) (710)
Other investing activities (27) (1) (7) (25)
Net cash used in investing activities (6,418) (2,891) (1,002) (6,259) (1,438)
Payment for treasury shares (6,096) (3,833) (2,160) (3,257) (2,975)
Proceeds from short-term borrowing 5,709 100 6,112 2,567
Principal repayments on short-term borrowing (5,709) (100) (6,213) (3,012)
Proceeds from the issuance of long-term debt 4,452 3,468 7,913 2,471
Repayments of long-term debt (1,904) (514)
Net proceeds (payments) from common equity put options 8 (9) 10
Payment of contingent consideration (40) (41) (26)
Net proceeds from share-based compensation arrangements 144 685 359 252 297
Excess tax benefit from share-based compensation arrangements 189 301 251
Net cash provided by (used in) financing activities (1,540) (1,584) (1,646) 4,585 (417)
Effect of currency rate changes on cash and cash equivalents 8 72 (39) (51) (64)
Net increase (decrease) in cash and cash equivalents (2,779) 843 1,290 759 887
Cash and cash equivalents at beginning of period 7,013 6,170 4,880 4,122 3,234
Cash and cash equivalents at end of period 4,234 7,013 6,170 4,880 4,122

Based on: 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31).

Cash flow statement item Description The company
Net cash provided by operating activities Amount of cash inflow (outflow) from operating activities, excluding discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities. Celgene Corp. net cash provided by operating activities increased from 2016 to 2017 but then slightly decreased from 2017 to 2018.
Net cash used in investing activities Amount of cash inflow (outflow) of investing activities, excluding discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets. Celgene Corp. net cash used in investing activities decreased from 2016 to 2017 and from 2017 to 2018.
Net cash provided by (used in) financing activities Amount of cash inflow (outflow) of financing activities, excluding discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit. Celgene Corp. net cash provided by (used in) financing activities increased from 2016 to 2017 and from 2017 to 2018.